Suppr超能文献

相似文献

1
Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program.
J Thromb Haemost. 2022 Jul;20(7):1576-1588. doi: 10.1111/jth.15713. Epub 2022 Apr 6.
5
Laboratory diagnosis and molecular classification of von Willebrand disease.
Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8.
7
Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Blood. 2011 Feb 10;117(6):e67-74. doi: 10.1182/blood-2010-08-299016. Epub 2010 Dec 10.
9
Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study.
J Thromb Haemost. 2024 Nov;22(11):3010-3034. doi: 10.1016/j.jtha.2024.06.026. Epub 2024 Jul 11.
10
Clinical and laboratory phenotype variability in type 2M von Willebrand disease.
J Thromb Haemost. 2017 Aug;15(8):1559-1566. doi: 10.1111/jth.13742. Epub 2017 Jun 23.

引用本文的文献

1
Challenges and considerations of genetic testing in von Willebrand disease.
Res Pract Thromb Haemost. 2025 Jan 16;9(1):102686. doi: 10.1016/j.rpth.2025.102686. eCollection 2025 Jan.
2
Prevalence and characterization of anti-VWF antibodies in a population of patients with type 3 VWD.
Blood Adv. 2024 Oct 8;8(19):5051-5061. doi: 10.1182/bloodadvances.2024013095.
3
von Willebrand disease.
Nat Rev Dis Primers. 2024 Jul 25;10(1):51. doi: 10.1038/s41572-024-00536-8.
4
Application of genetic testing for the diagnosis of von Willebrand disease.
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.

本文引用的文献

1
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Blood Adv. 2021 Aug 10;5(15):2987-3001. doi: 10.1182/bloodadvances.2020003397.
2
Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease.
J Thromb Haemost. 2021 Jan;19(1):96-106. doi: 10.1111/jth.15116. Epub 2020 Oct 23.
3
The mutational constraint spectrum quantified from variation in 141,456 humans.
Nature. 2020 May;581(7809):434-443. doi: 10.1038/s41586-020-2308-7. Epub 2020 May 27.
6
Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease.
Haemophilia. 2019 Nov;25(6):1035-1044. doi: 10.1111/hae.13841. Epub 2019 Sep 18.
7
Predicting Splicing from Primary Sequence with Deep Learning.
Cell. 2019 Jan 24;176(3):535-548.e24. doi: 10.1016/j.cell.2018.12.015. Epub 2019 Jan 17.
8
CADD: predicting the deleteriousness of variants throughout the human genome.
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894. doi: 10.1093/nar/gky1016.
9
Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.
J Thromb Haemost. 2017 Jul;15(7):1403-1411. doi: 10.1111/jth.13722. Epub 2017 Jun 6.
10
Genome-wide association studies identify genetic loci for low von Willebrand factor levels.
Eur J Hum Genet. 2016 Jul;24(7):1096. doi: 10.1038/ejhg.2016.21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验